Gene: C21orf91
Official Full Name: chromosome 21 open reading frame 91provided by HGNC
Gene Summary: Predicted to be involved in cerebral cortex neuron differentiation and positive regulation of dendritic spine development. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21828 | C21orf91 Knockout cell line (HeLa) | Human | C21orf91 | 1:3~1:6 | Negative | Online Inquiry |
KO21829 | C21orf91 Knockout cell line (HCT 116) | Human | C21orf91 | 1:2~1:4 | Negative | Online Inquiry |
KO21830 | C21orf91 Knockout cell line (HEK293) | Human | C21orf91 | 1:3~1:6 | Negative | Online Inquiry |
KO21831 | C21orf91 Knockout cell line (A549) | Human | C21orf91 | 1:3~1:4 | Negative | Online Inquiry |
C21orf91 Gene Knockout Cell Lines represent a cutting-edge tool for researchers aiming to explore the functional implications of the C21orf91 gene within various biological contexts. These genetically modified cell lines have been specifically designed to facilitate the investigation of gene function, regulatory mechanisms, and disease pathogenesis by providing a clean model system where the C21orf91 gene is completely disrupted. The knockout strategy typically involves CRISPR-Cas9 technology, leading to precise genomic modifications that enable the study of gene role in cellular processes such as proliferation, differentiation, and response to stress.
The key function of C21orf91 Gene Knockout Cell Lines lies in their ability to mimic natural loss-of-function scenarios, which are crucial for advancing our understanding of genetic contributions to human health and disease. By employing these cell lines, researchers can perform a range of applications, including drug screening, pathway analysis, and the elucidation of molecular interactions, thereby paving the way for targeted therapeutic development. Furthermore, these cell lines can be invaluable in studying genetic disorders associated with aberrant C21orf91 function, allowing for novel insights into potential therapeutic targets.
What sets C21orf91 Gene Knockout Cell Lines apart is their high level of specificity and precision in gene editing, which minimizes off-target effects common in traditional knockout methods. These lines also undergo rigorous validation processes to ensure reproducibility and reliability in experimental setups. As a result, researchers can trust that their findings are based on robust genetic models rather than ambiguous outcomes.
The value of C21orf91 Gene Knockout Cell Lines to the scientific community cannot be overstated. They empower researchers and clinicians alike to tackle complex biological questions, enhancing our molecular understanding of diseases and promoting advancements in precision medicine. By choosing our cell lines, users gain access to a product that embodies quality, innovation, and extensive scientific validation, reinforcing our commitment to advancing research in the life sciences. Our company specializes in developing high-quality biological products, leveraging decades of expertise to support researchers at the forefront of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.